Eosinophils in asthma--closing the loop or opening the door?

Editorial

Sally E Wenzel. N Engl J Med. 2009.

. 2009 Mar 5;360(10):1026-8.

doi: 10.1056/NEJMe0900334.

No abstract available

Comment in

Anti-interleukin-5 therapy and severe asthma.
Gleich GJ. Gleich GJ. N Engl J Med. 2009 Jun 11;360(24):2577; author reply 2578. N Engl J Med. 2009. PMID: 19522047 No abstract available.

Mepolizumab and exacerbations of refractory eosinophilic asthma.
Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, Marshall RP, Bradding P, Green RH, Wardlaw AJ, Pavord ID. Haldar P, et al. N Engl J Med. 2009 Mar 5;360(10):973-84. doi: 10.1056/NEJMoa0808991. N Engl J Med. 2009. PMID: 19264686 Free PMC article. Clinical Trial.
Mepolizumab for prednisone-dependent asthma with sputum eosinophilia.
Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, Hargreave FE, O'Byrne PM. Nair P, et al. N Engl J Med. 2009 Mar 5;360(10):985-93. doi: 10.1056/NEJMoa0805435. N Engl J Med. 2009. PMID: 19264687 Clinical Trial.